Perchtoldsdorf, Austria

Ulrich Elling

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Ulrich Elling: Pioneering Conditional CRISPR Technologies

Introduction: Ulrich Elling, an accomplished inventor based in Perchtoldsdorf, Austria, has made significant contributions to the field of molecular biotechnology. With a focus on innovative solutions within the CRISPR/Cas9 system, his work showcases the intersection of creativity and scientific advancement.

Latest Patents: Ulrich Elling holds a notable patent titled "Conditional CRISPR sgRNA expression." This patent describes an expression cassette designed for the conditional expression of a single guide RNA (sgRNA) used in the CRISPR/Cas9 system. The inventive cassette comprises a promoter, an sgRNA sequence, and features flanked by at least a pair of recombinase recognition sites. This technology enables recombinase-activated recombination that can excise the flanked sequence, allowing for sophisticated control over gene editing applications. The conditional expression methods outlined in his patent have opened new avenues in genetic research and therapeutic strategies.

Career Highlights: Throughout his career, Ulrich has been associated with leading institutions in the biotechnology field. Notably, he has worked at the Institute of Molecular Biotechnology (IMBA) and Campus Science Support Facilities GmbH. His roles within these prominent organizations have contributed to advancing the understanding and application of CRISPR technology.

Collaborations: Collaborating with esteemed scientists in the field, Ulrich has worked alongside Krzysztof Chylinski and Maria Hubmann. These collaborations have been instrumental in pushing the boundaries of research in genetic engineering and functional genomics.

Conclusion: Ulrich Elling is a significant figure in the realm of CRISPR technologies, known for his inventive approach to biotechnology. His patent on conditional sgRNA expression exemplifies innovation that stands to benefit both academic research and practical applications in genetics. As the field continues to evolve, the contributions of inventors like Ulrich Elling remain essential to unlocking new possibilities in science and medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…